Arrowhead Pharmaceuticals

ARWR

0 Obserwujący

$13.61

+2.72%

$0.36

Obserwuj

12 Maj

Upcoming Earnings

Market Cap.

P/E

Overview Metrics Financials

ARWR Fair Price

$00.88

Undervalued by 69.4%

Aby wyświetlić sprawiedliwą cenę akcji, musisz być członkiem Bulios Black.

My Notes

Začít psát

Profile

Arrowhead Pharmaceuticals is a U.S.-based biotechnology company focused on developing innovative therapies targeting genetic diseases. The company is particularly known for its advanced RNA interference (RNAi) technology, which enables the "turning off" or regulation of genes associated with various diseases. Arrowhead Pharmaceuticals focuses on developing drugs for the treatment of rare and chronic conditions, including genetic disorders, viral infections, and cardiovascular diseases, aiming to improve treatment outcomes and the quality of life for patients.

Feed

There are no posts to show right now.